Syndax Pharmaceuticals Reports $49.4M Third-Quarter Loss
Story updates
09:01:40 PM UTC
SquawkNews
Syndax Pharmaceuticals 3Q Loss/Shr 55c >SNDX
09:01:51 PM UTC
SquawkNews
Syndax Pharmaceuticals 3Q Rev $83.3M >SNDX
09:02:08 PM UTC
SquawkNews
Nov 02 (Reuters) - Syndax Pharmaceuticals Q3 net income USD -49.433 million vs. IBES estimate USD -45.2 million.
09:09:23 PM UTC
SquawkNews
Syndax reported 3Q26 revenue of $83.3M, up 82% year over year, and a net loss of $49.4M, or $0.55 per share, versus $60.7M, or $0.70 per share, a year earlier. It expects 2026 R&D and SG&A expenses of approximately $400M, excluding estimated $50M non-cash stock compensation.Material DetailsContext…
09:11:46 PM UTC
SquawkNews
Syndax Pharmaceuticals reported third-quarter 2026 revenue of $83.3 million, up 81.6% from $45.9 million a year earlier, while its net loss narrowed to $49.4 million from $60.7 million. Diluted loss per share was $0.55, compared with $0.7 in the prior-year quarter.Financial HighlightsBusiness Highl…